Free Trial

Appili Therapeutics (APLIF) Short Interest Ratio & Short Volume

Appili Therapeutics logo
$0.03 0.00 (0.00%)
(As of 11/22/2024 ET)

Appili Therapeutics Short Interest Data

Appili Therapeutics (APLIF) has a short interest of 7,800 shares. This marks a 310.53% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 98,485 shares to cover all short positions.

Current Short Interest
7,800 shares
Previous Short Interest
1,900 shares
Change Vs. Previous Month
+310.53%
Dollar Volume Sold Short
$206.70
Short Interest Ratio
0.0 Days to Cover
Last Record Date
October 31, 2024
Today's Trading Volume
211 shares
Average Trading Volume
98,485 shares
Today's Volume Vs. Average
0%
Short Selling Appili Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Appili Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

APLIF Short Interest Over Time

APLIF Days to Cover Over Time

APLIF Percentage of Float Shorted Over Time

Appili Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/20247,800 shares $206.70 +310.5%N/A0 $0.03
10/15/20241,900 shares $45.22 -99.0%N/A0 $0.02
9/30/2024198,900 shares $5,171.40 No ChangeN/A0.7 $0.03
8/31/20241,000 shares $29.10 -94.4%N/A0 $0.03
8/15/202417,800 shares $428.98 +2,866.7%N/A0.1 $0.02
7/31/2024600 shares $15.88 No ChangeN/A0 $0.03
6/15/202427,300 shares $839.75 -3.5%N/A0.4 $0.03
5/31/202428,300 shares $724.48 -28.4%N/A0.2 $0.03
5/15/202439,500 shares $1,027.00 +26.2%N/A0.3 $0.03
4/30/202431,300 shares $939.00 -16.3%N/A1 $0.03
4/15/202437,400 shares $942.48 -69.9%N/A0 $0.03
3/31/2024124,200 shares $2,657.88 +42.9%N/A7.2 $0.02
3/15/202486,900 shares $1,929.18 +16.5%N/A0.3 $0.02
2/29/202474,600 shares $1,618.82 +106.1%N/A0.1 $0.02
2/15/202436,200 shares $807.26 -5.0%N/A0.2 $0.02
1/15/202439,300 shares $884.25 -4.8%N/A0.1 $0.02
12/31/202341,300 shares $1,094.45 -2.1%N/A0.6 $0.03
12/15/202342,200 shares $1,055.00 -2.3%N/A1.3 $0.03
11/30/202343,200 shares $1,028.16 -47.4%N/A0.3 $0.02
11/15/202382,100 shares $1,814.41 +81.6%N/A1.1 $0.02
10/31/202345,200 shares $1,301.76 -35.8%N/A0.4 $0.03
10/15/202370,400 shares $2,112.00 +4.1%N/A0.2 $0.03
9/30/202367,600 shares $2,804.05 +37.4%N/A0 $0.04
9/15/202349,200 shares $1,968.00 No ChangeN/A0.3 $0.04
8/31/202349,200 shares $1,972.92 -53.7%N/A0.2 $0.04
8/15/2023106,200 shares $3,823.20 -33.8%N/A0.2 $0.04
7/31/2023160,400 shares $7,185.92 +226.0%N/A0.1 $0.04
7/15/202349,200 shares $1,520.28 -22.2%N/A0.1 $0.03
6/30/202363,200 shares $1,390.40 +14.5%N/A0.5 $0.02
6/15/202355,200 shares $1,269.60 +10.0%N/A2.7 $0.02
5/31/202350,200 shares $1,417.65 -3.3%N/A3.3 $0.03
5/15/202351,900 shares $1,385.73 +1.4%N/A0.8 $0.03
4/30/202351,200 shares $1,505.28 No ChangeN/A1 $0.03
4/15/202351,200 shares $1,315.84 No ChangeN/A13.8 $0.03
3/31/202351,200 shares $1,295.36 No ChangeN/A0.5 $0.03
3/15/202351,200 shares $1,720.32 -4.5%N/A7.9 $0.03
2/28/202353,600 shares $1,817.04 +4.7%N/A5.7 $0.03
2/15/202351,200 shares $4,096.00 -1.9%N/A0.9 $0.08
1/31/202352,200 shares $2,124.54 No ChangeN/A1.9 $0.04
1/15/202352,200 shares $2,453.40 -13.9%N/A3.5 $0.05
9 hidden AI stocks set to thrive in Trump’s new era (Ad)

AI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be worth trillions of dollars (here’s how to tap into this new wealth)

Get the Name of These AI Picks Now
12/30/202260,600 shares $2,187.66 -10.2%N/A0.7 $0.04
12/15/202267,500 shares $3,003.75 +12.1%N/A1.6 $0.04
11/30/202260,200 shares $2,100.98 -10.4%N/A7.3 $0.03
11/15/202267,200 shares $2,197.44 -6.9%N/A2.4 $0.03
10/31/202272,200 shares $3,046.84 -5.3%N/A14.7 $0.04
10/15/202276,200 shares $2,739.39 -1.3%N/A8.9 $0.04
9/30/202277,200 shares $3,010.80 -1.3%N/A0.9 $0.04
9/15/202278,200 shares $3,503.36 -33.2%N/A1.7 $0.04
8/31/2022117,100 shares $5,491.99 -17.0%N/A8.9 $0.05
8/15/2022141,100 shares $8,697.40 +7.1%N/A13.7 $0.06
7/31/2022131,700 shares $6,775.97 +24.6%N/A13.7 $0.05
7/15/2022105,700 shares $5,348.42 +16.4%N/A1.8 $0.05
6/30/202290,800 shares $5,284.56 No ChangeN/A2.4 $0.06
6/15/202290,800 shares $4,939.52 -44.3%N/A4.5 $0.05
5/31/2022162,900 shares $9,774.00 -0.8%N/A8.8 $0.06
5/15/2022164,200 shares $12,725.50 -16.8%N/A10.9 $0.08
4/30/2022197,400 shares $16,591.47 -14.0%N/A23.5 $0.08
4/15/2022229,400 shares $21,242.44 +1.1%N/A3.6 $0.09
3/31/2022226,900 shares $22,190.82 -3.5%N/A24.4 $0.10
3/15/2022235,100 shares $20,007.01 +9.4%N/A2.3 $0.09
2/28/2022214,900 shares $23,789.43 -8.9%N/A3 $0.11
2/15/2022235,900 shares $22,811.53 +2.3%N/A3.3 $0.10
1/31/2022230,700 shares $21,778.08 +61.0%N/A1.6 $0.09
1/15/2022143,300 shares $12,997.31 +34.2%N/A2 $0.09
12/31/2021106,800 shares $9,579.96 -53.2%N/A1.6 $0.09
12/15/2021228,000 shares $16,735.20 +2.6%N/A0.7 $0.07
11/30/2021222,200 shares $26,664.00 +14.8%N/A0.6 $0.12
11/15/2021193,600 shares $34,906.08 +15.2%N/A0.3 $0.18
10/29/2021168,000 shares $103,051.20 +313.8%N/A1.1 $0.61
10/15/202140,600 shares $23,978.36 -74.2%N/A0.3 $0.59
9/30/2021157,200 shares $135,034.80 +30.5%N/A1 $0.86
9/15/2021120,500 shares $90,965.45 +16.2%N/A1.1 $0.75
8/31/2021103,700 shares $64,605.10 +2.4%N/A1.4 $0.62
8/13/2021101,300 shares $56,728.00 +3.2%N/A1.4 $0.56
7/30/202198,200 shares $64,075.50 +2.2%N/A1.7 $0.65
7/15/202196,100 shares $48,050.00 +15.8%N/A2.7 $0.50
6/30/202183,000 shares $46,338.90 -6.2%N/A1.1 $0.56
6/15/202188,500 shares $54,117.75 +19.1%N/A0.5 $0.61
5/28/202174,500 shares $54,166.72 -8.3%N/A0.5 $0.73
5/14/202181,200 shares $71,610.28 +140.2%N/A0.6 $0.88
4/30/202133,800 shares $34,104.20 +84.7%N/A0.3 $1.01
4/15/202118,300 shares $14,656.47 -3.2%N/A0.2 $0.80
3/31/202118,900 shares $16,053.66 -2.6%N/A0.2 $0.85
3/15/202119,400 shares $16,206.76 +68.7%N/A0.5 $0.84
2/26/202111,500 shares $10,213.15 -62.8%N/A0.1 $0.89
2/12/202130,900 shares $33,372.00 +147.2%N/A0.2 $1.08
1/29/202112,500 shares $9,750.00 +197.6%N/A0.4 $0.78
1/15/202115,700 shares $13,721.80 +190.7%N/A0.2 $0.87
12/31/20204,600 shares $4,232.00 -70.7%N/A0.1 $0.92
12/15/202015,700 shares $16,328.00 +190.7%N/A0.2 $1.04
9 hidden AI stocks set to thrive in Trump’s new era (Ad)

AI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be worth trillions of dollars (here’s how to tap into this new wealth)

Get the Name of These AI Picks Now
11/30/20205,400 shares $5,319.00 -70.2%N/A0.1 $0.99
11/15/202018,100 shares $16,677.34 +805.0%N/A0.3 $0.92
10/30/20202,000 shares $2,040.00 -4.8%N/A0.1 $1.02
10/15/20202,100 shares $2,079.00 +23.5%N/A0.1 $0.99

APLIF Short Interest - Frequently Asked Questions

What is Appili Therapeutics' current short interest?

Short interest is the volume of Appili Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 7,800 shares of APLIF short. Learn More on Appili Therapeutics' current short interest.

Is Appili Therapeutics' short interest increasing or decreasing?

Appili Therapeutics saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 7,800 shares, an increase of 310.5% from the previous total of 1,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Appili Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Appili Therapeutics: Antibe Therapeutics Inc. (0.12%), Apollomics, Inc. (0.25%), BetterLife Pharma Inc. (0.02%), ImmunoPrecise Antibodies Ltd. (3.05%), Indaptus Therapeutics, Inc. (1.85%), Oncotelic Therapeutics, Inc. (0.00%), Imunon, Inc. (3.52%), Mustang Bio, Inc. (1.59%), Kiora Pharmaceuticals, Inc. (1.76%), Conduit Pharmaceuticals Inc. (3.47%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Appili Therapeutics stock?

Short selling APLIF is an investing strategy that aims to generate trading profit from Appili Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Appili Therapeutics?

A short squeeze for Appili Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of APLIF, which in turn drives the price of the stock up even further.

How often is Appili Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APLIF, twice per month. The most recent reporting period available is October, 31 2024.




This page (OTCMKTS:APLIF) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners